Back to
Royal Bank of Canada
VIR
Showing 8 of 27 quarters
Position history for
Royal Bank of Canada's holdings in Vir Biotechnology, Inc.
Yes. Royal Bank of Canada holds 14,910 shares of VIR (Vir Biotechnology), worth $153,000, as of its Q2 2026 13F filing. It reduced the position by 445 shares (-2.9%) from Q1 2026. Royal Bank of Canada has held VIR in every 13F on record since Q4 2019, 27 quarterly filings.
Current Value
$153,000
Current Shares
14,910
Total Value Change
+$59,000
Total Shares Change
+2,459
Quarter-by-Quarter History